Certified by Founder
Lodge
AI Proteins
start up
United States
- Boston, Massachusetts
- 21/11/2025
- Series A
- $41,500,000
Boston-based AI Proteins is a biotech company on a mission to re-imagine protein therapeutics with a novel approach for designing entirely new proteins. Using AI-enabled design and a high-throughput drug discovery platform, AI Proteins creates de novo miniproteins optimized for a variety of therapeutic applications. Partnered with leading biopharmaceutical companies, AI Proteins continues to pursue collaborations across a wide variety of therapeutic areas in addition to advancing its internal pipeline. The AI Proteins platform can dramatically accelerate the development of lead therapeutic candidates ready for IND-enabling studies.
- Industry Biotechnology Research
- Website https://www.aiproteins.com/
- LinkedIn https://www.linkedin.com/company/aiproteins/
Related People
Chris BahlFounder
United States -
Boston, Massachusetts
N/A
LinkedIn
https://www.linkedin.com/in/cdbahl/
Davis AI | $5,500,000 | (May 8, 2026)
Balcony | $12,700,000 | (May 8, 2026)
Jetty | $2,000,000 | (May 8, 2026)
ParcelBio | $13,000,000 | (May 8, 2026)
Jesse & Ben's | $10,000,000 | (May 8, 2026)
SageOx | $15,000,000 | (May 8, 2026)
CodeWords | $9,000,000 | (May 8, 2026)
Ethos | $22,750,000 | (May 8, 2026)
illoca | $13,000,000 | (May 8, 2026)
Lithosquare | $25,000,000 | (May 8, 2026)
Jurisphere.ai | $2,200,000 | (May 8, 2026)
OpsMill | $14,000,000 | (May 8, 2026)